Who has invested in Ascend Gene & Cell Therapies?

Abingworth, Michael Beecham, ED Mathers, Rivervest, Andrew Kozlov, Ajinomoto are named among the investors backing Ascend Gene & Cell Therapies.

Ascend Gene & Cell Therapies Funding: $66M Raised, Series A

Ascend Gene & Cell Therapies funding overview

Ascend Gene & Cell Therapies is based in Potters Bar, United Kingdom. Ascend Gene & Cell Therapies has raised $66M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2023. The round record for Ascend Gene & Cell Therapies runs through 2023; nothing later has been disclosed. Investors on record include Abingworth, Michael Beecham, ED Mathers, Rivervest, Andrew Kozlov, Ajinomoto and 4 others. 10 distinct backers are named across the disclosed rounds.

Ascend Gene & Cell Therapies at a glance

Total raised: $66M
Latest round: Series A
Latest round date: May 2023
Headquarters: Potters Bar, United Kingdom
Notable investors: Abingworth, Michael Beecham, ED Mathers, Rivervest, Andrew Kozlov, Ajinomoto, JIA YI HAR, Eric Shiozaki

Frequently asked about Ascend Gene & Cell Therapies funding

How much has Ascend Gene & Cell Therapies raised?: Ascend Gene & Cell Therapies has raised $66M in total disclosed funding across the rounds on record.
Who has invested in Ascend Gene & Cell Therapies?: Abingworth, Michael Beecham, ED Mathers, Rivervest, Andrew Kozlov, Ajinomoto are named among the investors backing Ascend Gene & Cell Therapies.
What was the latest Ascend Gene & Cell Therapies funding round?: The most recent disclosed round is a Series A, announced in May 2023.
Where is Ascend Gene & Cell Therapies based?: Ascend Gene & Cell Therapies is based in Potters Bar, United Kingdom.
When did Ascend Gene & Cell Therapies last raise?: The last disclosed Ascend Gene & Cell Therapies round closed in May 2023 at Series A.

Every Ascend Gene & Cell Therapies figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Potters Bar at a similar stage.

Ascend Gene & Cell Therapies Funding: $66M Raised, Series A

Ascend Gene & Cell Therapies funding overview

Ascend Gene & Cell Therapies at a glance

Frequently asked about Ascend Gene & Cell Therapies funding

Companies related to Ascend Gene & Cell Therapies (19)

Browse related funding lists (4)